Project Number 5R01AG031896-05 Agency/Funding Organization NIA Funding Year 2013 View Full Project Details for CYCLOHEXANEHEXOL THERAPY IN TRANSGENIC MODELS OF ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator DEDEOGLU, ALPASLAN Principal Investigator First Name ALPASLAN Principal Investigator Last Name DEDEOGLU Awardee Organization BOSTON UNIVERSITY MEDICAL CAMPUS Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PA-07-070: RESEARCH PROJECT GRANT (PARENT R01) FY Overall Cost $360,859 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO Related Resources Repository [AlzPED] R-flurbiprofen improves tau, but not Aß pathology in a triple transgenic model of Alzheimer's disease.
